Design of Receptor-Specific Anticancer Agents for Gallbladder Cancer: Integrating Immunomodulatory Strategies.
INTRODUCTION Gallbladder Cancer (GBC) remains one of the most aggressive biliary tract malignancies, frequently diagnosed at an advanced stage due to its subtle early symptoms. This review examines receptor-mediated drug delivery as a promising approach to address the challenges of late diagnosis, limited treatment opt...